Dexanabinol promising in severe head injury

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1334, 2002-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular and Cellular Mechanisms in the Pathophysiology of Severe Head Injury

Current Pharmaceutical Design, Vol. 10, Iss. 18, 2004-07 ,pp. : 2131-2143

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetic Alterations After Severe Head Injury: Clinical Relevance

By Boucher B.A.

Clinical Pharmacokinetics, Vol. 35, Iss. 3, 1998-09 ,pp. : 209-221

Adis International

Access to resources Recommend Favorite

Current Aspects of Pathophysiology and Cell Dysfunction after Severe Head Injury

Current Pharmaceutical Design, Vol. 7, Iss. 15, 2001-10 ,pp. : 1475-1503

Bentham Science Publishers

Access to resources Recommend Favorite

Arterial Hyperoxia in Severe Head Injury: A Useful or Harmful Option?

Current Pharmaceutical Design, Vol. 10, Iss. 18, 2004-07 ,pp. : 2163-2176

Bentham Science Publishers

Access to resources Recommend Favorite

The optimization of cortical function in patients with severe head injury during gliatiline (alpha-GPC) treatment

By Madorsky S.V.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 381-382

Elsevier

Access to resources Recommend Favorite